Exsilio Therapeutics logo

Exsilio Therapeutics Funding & Investors

Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells.

exsiliotx.com

Total Amount Raised: $82,000,000

Exsilio Therapeutics Funding Rounds

  • Series A

    $82,000,000

    Series A Investors

    Delos Capital
    Novartis Venture Fund
    OrbiMed Advisors
    CRISPR Therapeutics
    Insight Partners
    Invus Group
    Innovation Endeavors
    JPMorgan Chase
    Deep-Insight
    Deep Insight
    Arc Ventures
Funding info provided by Diffbot.